Josep C.
- Country
- Spain
- Department
- Nephrology
Research Overview
- Evaluation of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease: A Randomized Controlled Trial
- Evaluation of Siplizumab Versus Rabbit Anti-Thymocyte Globulin in Induction Therapy for de novo Renal Transplant Recipients
- Efficacy and Safety of Cagrilintide and Semaglutide in Patients with Type 2 Diabetes, Chronic Kidney Disease, and Overweight or Obesity
Data & Insights
Has run more than one trial at 5 of 128 partner sites.
Specializations
Transplant Nephrology
The investigator specializes in kidney transplant medicine, with particular focus on post-transplant complications and rejection prevention strategies.
- Post-transplant glomerulopathy management
- Immunosuppression optimization
- Transplant recipient care
Their work includes evaluation of novel therapeutic approaches for transplant recipients.
Chronic Kidney Disease
The investigator focuses on progressive kidney disease treatment, exploring innovative therapeutic options for both diabetic and non-diabetic conditions.
- Non-diabetic kidney disease management
- Disease progression prevention
- Novel therapeutic agents evaluation
Their research encompasses various stages of chronic kidney disease from early intervention to advanced care.
Cardio-Renal Medicine
The investigator explores the intersection of cardiac and renal conditions, with emphasis on comprehensive patient outcomes.
- Heart failure in kidney disease
- Mortality risk reduction
- Combined cardiovascular-renal treatments
Their research includes evaluation of treatments affecting both cardiovascular and renal systems.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.